Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,200,939
in 8 filings

Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-07-10 Sethuraman Natarajan Chief Scientific Officer Sale 10b5-1 −3,026 $18.00 $54K 168,299
2023-06-29 WENTWORTH KORY JAMES Chief Financial Officer Option exercise +8,790 $2.10 $18K 36,747
2023-06-29 WENTWORTH KORY JAMES Chief Financial Officer Option exercise · Stock Option (Right to Buy) −8,790 74,657
2023-06-22 Dowden Nathan J Chief Operating Officer Sale 10b5-1 −7,097 $16.02 $114K 42,473
2023-06-21 WENTWORTH KORY JAMES Chief Financial Officer Option exercise 10b5-1 +17,500 $2.10 $37K 45,457
2023-06-21 WENTWORTH KORY JAMES Chief Financial Officer Sale 10b5-1 −8,593 $14.84 $128K 36,864
2023-06-21 WENTWORTH KORY JAMES Chief Financial Officer Sale 10b5-1 −8,907 $15.17 $135K 27,957
2023-06-21 WENTWORTH KORY JAMES Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −17,500 83,447
2023-06-20 Dowden Nathan J Chief Operating Officer Sale 10b5-1 −8,885 $14.94 $133K 49,570
2023-06-08 PARMAR KUSH Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2023-06-08 Thistle Mary Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2023-06-08 Crowley John F Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2023-06-08 KIM PETER S Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2023-04-27 Doshi Dipal President and CEO Sale 10b5-1 −2,000 $13.71 $27K 202,069
2023-04-17 Doshi Dipal President and CEO Sale 10b5-1 −2,092 $18.01 $38K 204,069
2023-04-17 Sethuraman Natarajan Chief Scientific Officer Sale 10b5-1 −3,961 $18.00 $71K 171,325
2023-04-04 Zeiher Bernhardt G Director Grant or award · Stock Option (Right to Buy) +32,000 32,000
2023-03-27 Doshi Dipal President and CEO Sale 10b5-1 −1,800 $14.63 $26K 256,011
2023-03-27 Doshi Dipal President and CEO Sale 10b5-1 −200 $15.51 $3K 255,811
2023-03-02 WENTWORTH KORY JAMES Chief Financial Officer Shares withheld for taxes −1,005 $11.60 $12K 43,904

Page 16 of 26 · 517 trades